WHO IGAP Toolkit

On July 8th, the WHO will present the IGAP toolkit for the Intersectoral global action plan on epilepsy and other neurological (IGAP). The development of the toolkit has been supported by the World Federation of Neurology.

IGAP was adopted in May 2022 with a 10-year action horizon, 2022-2031. The plan has proposed actions for Member States, WHO Secretariat and International and National Partners with 10 global targets with the deadline of 2031. Countries can set their own national targets to customise IGAP to their national circumstances and challenges. But there is a need for translating the high-level IGAP into practical steps and actions.

WFN IGAP Leaflet

WFN IGAP Information Leaflet

There are many implementation tools and resources about neurology already available, and so the IGAP implementation toolkit is centred on the vision, goal, strategic objectives and targets of the Intersectoral Global Action Plan. 

The toolkit is intended to support country-level stakeholders—policy makers, national and subnational programme managers in various sectors, including health, social, education, justice and employment—in planning how to achieve IGAP targets and customise the actions set out in IGAP to their national situation through practical resources for step-by-step planning;  It is also relevant for the research, donor and development community as a blueprint for meeting the targets in the action plan.

The toolkit complements the development of national plans and strategies for neurological disorders by listing actions and suggesting tools and resources that can be utilised to realise fully the vision of IGAP.  It details the framework for an integrated approach to neurological disorders which underpins IGAP, and will allow stakeholders to strengthen efforts for better care, treatment and prevention of neurological disorders, as well as enhancing the promotion of brain health. 

75th WHA

Recognising the importance of responding to the challenge posed by neurological disorders, the 75th World Health Assembly adopted iGAP that was unanimously endorsed by member states. This led to  the formation of a distinct Brain Health Unit  within the WHO's Department of Mental Health and Substance Use (MSD) that has established a strong foundation for the integration of neurological disorders into the broader public health agendas.